ARCA biopharma competitorsClear all

ARCA biopharma's top competitors include LogicBio Therapeutics, Sarepta Therapeutics, Intellia Therapeutics and CRISPR Therapeutics.
ARCA biopharma
ARCA biopharma
ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.
LogicBio Therapeutics
LogicBio Therapeutics
LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.
Intellia Therapeutics
Intellia Therapeutics
Intellia is developing therapeutic products to help people with genetic diseases.
CRISPR Therapeutics
CRISPR Therapeutics
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Founding Date
Founding Date
2009
Founding Date
2014
Founding Date
1980
Founding Date
2014
Founding Date
2013
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Westminster, US HQ
Aurora, US
Westminster, US
Locations
Lexington, US HQ
Locations
Cambridge, US HQ
Boulogne Billancourt, FR
Berlin, DE
Dublin, IE
Milano, IT
Chiyoda City, JP
see more
Locations
Cambridge, US HQ
Locations
Zug, CH HQ
Greater London, GB
Cambridge, US
San Francisco, US
Employees
Employees
940% decrease
Employees
4178% increase
Employees
74349% increase
Employees
27028% increase
Employees
30462% increase
Valuation ($)
Valuation ($)
24.7 m
Valuation ($)
129.4 m
Valuation ($)
11.3 b
Valuation ($)
1.2 b
Valuation ($)
5.9 b
Twitter followers
Twitter followers
N/A
Twitter followers
361
Twitter followers
2.7 k
Twitter followers
4.6 k
Twitter followers
8.2 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
5
Number of tweets (last 30 days)
22
Number of tweets (last 30 days)
12
Number of tweets (last 30 days)
1
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.4
Average likes per tweet (last 30 days)
24.7
Average likes per tweet (last 30 days)
4.2
Average likes per tweet (last 30 days)
15
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
80%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
91.67%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
237524
Alexa Website Rank
365190
Alexa Website Rank
315290
Alexa Website Rank
264531
Alexa Website Rank
190330
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3
Employee Rating
3.4
Employee Rating
4.3

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$380.8m (FY, 2019)
Revenue (est.)
$43.1m (FY, 2019)
Revenue (est.)
$289.6m (FY, 2019)
Net income
Net income
($5.5m) (FY, 2019)
Net income
($40.1m) (FY, 2019)
Net income
($715.1m) (FY, 2019)
Net income
($99.5m) (FY, 2019)
Net income
$66.9m (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 7.2m
Total funding raised
$ 49m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 127m
For sources of this data, please see the company profile

View company profiles

LogicBio Therapeutics
HQ
Lexington, US
Employees
41

LogicBio Therapeutics develops lifelong cures for serious, early-onset rare diseases by combining gene therapy and gene editing in a one-time treatment.

View company
Sarepta Therapeutics
HQ
Cambridge, US
Employees
743↑ 49% increase

Sarepta Therapeutics is a biopharmaceutical company focused on developing innovative RNA-targeted therapeutics.

View company
Intellia Therapeutics
HQ
Cambridge, US
Employees
270↑ 28% increase

Intellia is developing therapeutic products to help people with genetic diseases.

View company
CRISPR Therapeutics
HQ
Zug, CH
Employees
304

CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.

View company